News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CLX Medical, Inc. (CLXN) Issues May 2008 Newsletter Reviewing Agreement to Acquire Additional Rapid Diagnostic Testing Product and Initiation of Process to Begin Validation Study for Zonda, Inc.'s Chlamydia Test



5/22/2008 10:38:06 AM

MURRIETA, CA--(Marketwire - May 22, 2008) - CLX Medical, Inc. (OTCBB: CLXN), which is focused on the launch and distribution of unique medical diagnostic testing products, today released the May 2008 edition of its investor newsletter, which reviews the announcement of a letter of intent to acquire a rapid diagnostic test for the medical market and the initiation of the first stages of a pre-clinical trials validation study on Zonda Incorporated's rapid point of care test for chlamydia.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES